Adjuvant therapy with pegylated interferon alfa-2a (PEG-IFN) versus low-dose interferon alfa-2a (IFN) in patients with malignant melanoma in stages IIa(T3a): IIIb (AJCC 2002)-Decog-trial

Eigentler, Thomas K. and Gutzmer, Ralf and Hauschild, Axel and Kaempgen, Eckhart and Schadendorf, Dirk and Nashan, Dorothee and Hoelzle, Erhard and Trefzer, Uwe and Becker, Juergen C. and Sunderkoetter, Cord and Moll, Ingrid and Richtig, Erika and Poenitzsch, Iris and Pehamberger, Hubert and Kaufmann, Roland and Pfoehler, Claudia and Vogt, Thomas and Berking, Carola and Praxmarer, Michael and Garbe, Claus (2014) Adjuvant therapy with pegylated interferon alfa-2a (PEG-IFN) versus low-dose interferon alfa-2a (IFN) in patients with malignant melanoma in stages IIa(T3a): IIIb (AJCC 2002)-Decog-trial. JOURNAL OF CLINICAL ONCOLOGY, 32 (15supp): 9071. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Petra Gürster
Date Deposited: 24 Jul 2020 08:47
Last Modified: 24 Jul 2020 08:47
URI: https://pred.uni-regensburg.de/id/eprint/10168

Actions (login required)

View Item View Item